Company / Current Assets per Share
Axsome Therapeutics, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$12.10
FY2025
5-year range
$2.30 / $12.10
FY2021-FY2025
Trend
+18.1%
vs FY2024
Sector context
#58 of 210
Health Care
What the data says
At $12.10, Axsome Therapeutics, Inc.'s current assets per share ranks #58 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 10 years, ranging from $0.57 in FY2018 to $12.10 in FY2025.
Based on SEC 10-K filings.
12.10 in FY2025 with a 5-year CAGR of +19.6%.
Improved from $11.59 to $12.10 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +23.1%
- 5-Year CAGR
- +19.6%
- 10-Year CAGR
- -
Sector benchmark
#58 of 210 in Health CareTop 28% of 210This company $12.10 Sector average $170.65
▼
-92.9% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 18.1% year-over-year.
- Ranks #58 out of 210 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.10 | +18.1% |
| FY2024 | $10.24 | -11.6% |
| FY2023 | $11.59 | +78.5% |
| FY2022 | $6.50 | +182.4% |
| FY2021 | $2.30 | -53.5% |
| FY2020 | $4.95 | -23.6% |
| FY2019 | $6.48 | +1044.6% |
| FY2018 | $0.57 | -63.5% |
| FY2017 | $1.55 | -21.9% |
| FY2016 | $1.98 | -51.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026